Pharmacokinetics of IL-23p19 Inhibitors: A Systematic Review Across Immune-Mediated Inflammatory Diseases (2026) Pool IA, de Groot AD, Keizer RJ, Dubinsky MC, Torres J, Atreya R, Malik P, et al. Journal article, Review article Population Pharmacokinetics of Bosutinib in Children with Philadelphia Chromosome-Positive Chronic Myelogenous Leukemia Based on a Phase I Dose-Finding Trial (ITCC-054/COG AAML1921) and Pediatric Recommended Phase II Dosage Evaluation (2026) Wu JH, Bautista F, Brivio E, Willemse M, Kowalski K, Jermain B, Garrett M, et al. Journal article Quantitative Pharmacology Justifying Ribociclib Dose in Early Breast Cancer (2026) Ji Y, Wang C, Combes FP, Ho YY, Fasching PA, Untch M, Zarate JP, Crown J Journal article Therapeutic Drug Monitoring of Imatinib in Paediatric Chronic Myeloid Leukaemia: Towards Practical Implementation and Interpretation of Measured Plasma Concentrations (2026) Lensker P, Gottschalk A, Zerjatke T, Roeder I, Fromm M, Dörje F, Suttorp M, et al. Journal article Validation of a Drug Transporter Probe Cocktail Using the Prototypical Inhibitors Rifampin, Probenecid, Verapamil, and Cimetidine (2020) Wiebe ST, Giessmann T, Hohl K, Schmidt-Gerets S, Hauel E, Jambrecina A, Bader K, et al. Journal article A Comprehensive Whole-Body Physiologically Based Pharmacokinetic Drug–Drug–Gene Interaction Model of Metformin and Cimetidine in Healthy Adults and Renally Impaired Individuals (2020) Hanke N, Türk D, Selzer D, Ishiguro N, Ebner T, Wiebe S, Müller F, et al. Journal article